The markets on 26 May 2025 will react to a slew of Q4FY25 earnings and F&O developments. Investors will track a mix of pharma, auto, energy, and capital goods companies reporting their March quarter results, alongside six stocks under the F&O ban list.
Key stocks that reported Q4 earning results
Glenmark Pharma reported a 6.3% year-on-year (YoY) rise in consolidated revenue to ₹3,256 crore. EBITDA rose 11.2% YoY to ₹561 crore with margin at 17.2%. Adjusted PAT stood at ₹347 crore, reflecting a margin of 10.6%.
Balkrishna Industries posted a 25% drop in standalone net profit to ₹362 crore in Q4FY25 due to rising input and employee costs. Revenue grew 5% YoY to ₹2,838 crore.
GE Vernova T&D India saw net profit jump nearly 3x YoY to ₹186.49 crore for the March quarter. Quarterly income rose to ₹1,173.65 crore from ₹919.31 crore. For FY25, net profit surged to ₹608.33 crore from ₹181.05 crore last year.
JSW Steel registered a 14% YoY rise in consolidated net profit to ₹1,501 crore in Q4, exceeding analyst expectations. Last year’s figure was ₹1,322 crore.
Ashok Leyland announced a 1:1 bonus issue—its first since 2011—and a ₹4.25 per share dividend. Q4 net profit surged 38.4% YoY to ₹1,246 crore, aided by a ₹173 crore tax credit. Revenue rose 5.7% YoY to ₹11,907 crore, just below CNBC-TV18’s poll estimate of ₹12,196 crore.
Finolex Industries reported a 5% decline in revenue to ₹1,171.8 crore. Net profit remained flat at ₹165 crore. EBITDA fell 18% to ₹171.3 crore, with margin contracting to 14.62% from 16.9%.
NTPC posted a 22.6% sequential rise in consolidated net profit to ₹5,778 crore for Q4FY24, slightly missing the estimated ₹5,810 crore. Revenue rose 6% QoQ to ₹43,903.7 crore but remained below expectations.
F&O ban stocks for 26 May 2025
Six stocks have been placed under the F&O ban list by the NSE for today’s session as they crossed 95% of the market-wide position limit:
-
CHAMBALFERT
-
DIXONTECH
-
HINDCOPPER
-
MANAPPURAM
-
RBLBANK
-
TITAGARH
No new positions are permitted in these stocks in the derivatives segment during the ban period.
Disclaimer: This article is for informational purposes only. Business Upturn does not provide any investment advice or stock recommendations. Investors are advised to consult with a qualified financial advisor before making any investment decisions.